Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.76 +2.93 (+3.97%)
At close: Nov 11, 2026 · 4:00 PM EST

Tarsus Pharmaceuticals (TARS) Cash & Current Investments (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Cash & Current Investments of $173.08 million for Q3 2026, down 40.1% from $289.11 million a year earlier and down 29.4% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Tarsus Pharmaceuticals' Cash & Current Investments came in at $233.63 million, up 18.9% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Cash & Current Investments was $196.56 million in FY2024 (-13.6%), $227.44 million in FY2023 (+4.8%), $217.03 million in FY2022 (+26.3%) and $171.82 million in FY2021 (+2.2%).
  • The Q3 2026 figure stands as the lowest quarterly Cash & Current Investments since Q3 2024.
  • On a year-over-year basis, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 37.7%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2024, with growth of 596.3%; the weakest was Q2 2023, with a decline of 70.9%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $245.1 million (Q2 2026), $286.54 million (Q1 2026) and $233.63 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn 309.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 309.61 Mn
Jun 30, 2026 449.69 Mn
Mar 31, 2026 388.73 Mn
Dec 31, 2025 417.27 Mn
Sep 30, 2025 401.84 Mn
Jun 30, 2025 381.14 Mn
Mar 31, 2025 407.92 Mn
Dec 31, 2024 291.38 Mn
Sep 30, 2024 316.95 Mn
Jun 30, 2024 323.58 Mn
Mar 31, 2024 298.52 Mn
Dec 31, 2023 227.44 Mn
Sep 30, 2023 246.89 Mn
Jun 30, 2023 178.23 Mn
Mar 31, 2023 201.22 Mn
Dec 31, 2022 217.03 Mn
Sep 30, 2022 226.57 Mn
Jun 30, 2022 245.40 Mn
Mar 31, 2022 175.30 Mn
Dec 31, 2021 171.82 Mn
API Access

Tarsus Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TARS&period=max&api_key=YOUR_API_KEY